Fig. 3.
Fig. 3. Lack of ecNOS protein expression detectable in B-CLL cells by flow cytometry. B-CLL cells from eight different patients and U937 cells (positive control of ecNOS expression) were permeabilized with the Cytoperm kit and labeled with either the monoclonal anti-ecNOS or unrelated IgG1 MoAb as an isotype-matched control, then incubated in the presence of a fluoresceinated goat F(ab′)2 anti-mouse Ig antibody. Fixed cells were analyzed by flow cytometry with a FACScan instrument, using the lysis II and Procyt softwares. Gray line, control labeling with IgG1; black line, labeling with anti-ecNOS. The data are representative of a total of 13 different B-CLL cell samples tested.

Lack of ecNOS protein expression detectable in B-CLL cells by flow cytometry. B-CLL cells from eight different patients and U937 cells (positive control of ecNOS expression) were permeabilized with the Cytoperm kit and labeled with either the monoclonal anti-ecNOS or unrelated IgG1 MoAb as an isotype-matched control, then incubated in the presence of a fluoresceinated goat F(ab′)2 anti-mouse Ig antibody. Fixed cells were analyzed by flow cytometry with a FACScan instrument, using the lysis II and Procyt softwares. Gray line, control labeling with IgG1; black line, labeling with anti-ecNOS. The data are representative of a total of 13 different B-CLL cell samples tested.

Close Modal

or Create an Account

Close Modal
Close Modal